Beverly Biller

Beverly MK Biller, MD Beverly MK Biller, MD, is Professor of Medicine at Harvard Medical School and a faculty member of the Neuroendocrine Unit at The Massachusetts General Hospital, Boston, Massachusetts, USA. Dr. Biller directs the Clinical Fellowship in adult Endocrinology and Metabolism at The Massachusetts General Hospital, and serves on the Accreditation Council of Graduate Medical Education Residency Review Committee which accredits all Internal Medicine and adult Endocrinology training programs in the United States. She also directs the annual Harvard Medical School & Massachusetts General Hospital Department of Continuing Education postgraduate course "Clinical Endocrinology" that welcomes endocrinologists from across the US and many international destinations to Boston every March. Major research interests include the pathogenesis, diagnosis and treatment of Cushing’s disease, acromegaly, prolactinomas, other pituitary tumors, and growth hormone deficiency in adults. Dr. Biller has published original research in many peer-reviewed journals and has also co-authored clinical guidelines regarding Cushing’s disease and adult growth hormone deficiency for the The Endocrine Society and the American Association of Clinical Endocrinologists, respectively.

Departments

• Neuroendocrinology
• Medicine

Clinical Interests

• Pituitary disease
• Prolactinomas
• Cushing's syndrome
• Acromegaly
• Hypopituitarism
• Growth hormone deficiency

Medical Education

• MD, University of Oklahoma College of Medicine
• Residency, Beth Israel Deaconess Medical Center
• Fellowship, Massachusetts General Hospital

Board Certifications

• Endocrinology
• Diabetes & Metabolism
• Internal Medicine

Research & Publications

Research Summary

Dr. Biller is a clinical investigator who focuses on pituitary disorders. Major research interests include the diagnosis and treatment of Cushing's disease, prolactinomas, acromegaly, other pituitary tumors and sellar masses as well as pituitary hormone deficiencies, including growth hormone deficiency in adults.

Publications

Selected research publications from 2012-2013

• van der Lely et al Long-Term Safety of Pegvisomant in Patients with Acromegaly...J Clin Endocrinol Metab. 2012 May; 97(5):1589
• Fleseriu et al Mifepristone, a glucocorticoid receptor antagonist.... J Clin Endocrinol Metab. 2012 Jun;97(6):2039
• Colao et al A 12-month phase III study of pasireotide in Cushing’s disease. N Engl J Med. 2012; 366:914
• Biller et al 12-Month effects of once-weekly sustained-release growth hormone treatment... Pituitary. 2012 Aug 23
• Bertagna et al LCI699, a potent 11ß-hydroxylase inhibitor, normalizes urinary cortisol ... J Clin Endocrinol Metab. 2013 Dec 10